CT-868
A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
Carmot Therapeutics, Inc · Phase 2 · Completed · Enrollment 103
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.